Skip to main content
CS
Cathryn Sundback
Assistant Professor, Harvard Medical School
Dr. Sundback is the Director of the Laboratory for Tissue Engineering and Organ Fabrication at the Massachusetts General Hospital.
CS
Published: Sep 15, 2020
This study employs micro-fluidic devices to test candidate therapeutics blocking SARS-CoV-2 entry and demonstrates amodiaquine efficacy in preclinical models. The claims presented in this work are reliable but could be strengthened through more rigorous model characterization.
CS
JB
AG
JW
Published: Sep 15, 2020
Reviewers: Cathryn Sundback (Massachusetts General Hospital) | 📘📘📘📘📘 • Jeffrey T Borenstein, Ashley L Gard (Draper), Jennifer P Wang (University of Massachusetts) | 📒📒📒 ◻️ ◻️
